| LVAD | Control | |
| Bleeding | 39.7% | 0% |
| Infection | 66% | 45.7% |
| Embolism CNS | 28.9% | 0% |
| Embolism non-CNS | ||
| 14.7% | 22.9% | |
| Hemolysis | 0.6% | 0% |
| Renal dysf. | 26.9% | 42.9% |
| RV dysf. | 10.3% | 14.3% |
| LVAD | Control | |
| Bleeding | 39.7% | 0% |
| Infection | 66% | 45.7% |
| Embolism CNS | 28.9% | 0% |
| Embolism non-CNS | ||
| 14.7% | 22.9% | |
| Hemolysis | 0.6% | 0% |
| Renal dysf. | 26.9% | 42.9% |
| RV dysf. | 10.3% | 14.3% |